Compare PALI & PHOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PALI | PHOS |
|---|---|---|
| Founded | 1996 | 2006 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.2M | 271.7M |
| IPO Year | 2019 | 2010 |
| Metric | PALI | PHOS |
|---|---|---|
| Price | $1.16 | $12.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $9.80 | N/A |
| AVG Volume (30 Days) | ★ 2.8M | 28.0K |
| Earning Date | 11-13-2026 | 11-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $260,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $1.10 | $10.97 |
| 52 Week High | $2.86 | $21.30 |
| Indicator | PALI | PHOS |
|---|---|---|
| Relative Strength Index (RSI) | 30.13 | 41.29 |
| Support Level | N/A | $10.97 |
| Resistance Level | $2.19 | $13.20 |
| Average True Range (ATR) | 0.11 | 1.09 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 13.57 | 26.48 |
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
First Phosphate Corp owns and is developing igneous rock phosphate mineral properties in the Saguenay Region of Quebec for the production of phosphoric acid for the production of cathode active material for use in lithium iron phosphate (LPF) batteries for the electric vehicle industry.